receptors, reducing the release of luteinizing hormone and follicular stimulating hormone and in turn androgen and oestrogen production. Indications for use of GnRH analogues include endometriosis, infertility, anaemia secondary to ®broids and cancer of the breast and prostate.
GnRH analogues have been used for prevention of cyclical attacks of AIP since 1984 2 , but therapy has usually been short-term. Patient 1 has now been on treatment for thirty-six months and preservation of bone mass is increasingly an issue. GnRH analogues are currently recommended (UK licensing guidelines) for a maximum of six months' treatment because of detrimental affects on bone mineralization 3 , although there are data to suggest that further courses of treatment may have little further longterm detrimental effect on bone density 4 and that concomitant administration of norethisterone may negate this effect 5 . Side-effects include menopause-like symptoms such as¯ushing, vaginal dryness and reduction in breast size 6 .
Both our patients were greatly relieved by treatment with nafarelin, and each withdrawal of the treatment led almost immediately to an attack of AIP (with hospital admission in patient 1). Both are keen to continue treatment. The potential drawback of this highly effective treatment is osteoporosis secondary to oestrogen de®ciency. Low-dose oestrogen replacement therapy, by either the oral or the transdermal route, precipitated AIP attacks in patient 1 but other bone-conserving therapies such as bone-speci®c oestrogens or bisphosphonates remain an option.
Pancreatic tumour with jaundice: good prognosis
Papillary cystic epithelial neoplasms of the pancreas (PCENP) are rare tumours that appear in women in the second or third decade of life. They are easily mistaken for more sinister neoplasms.
CASE HISTORY
A high-school girl, aged 15, was admitted for evaluation of a cholestatic syndrome (direct bilirubin 128 mmol/L, alkaline phosphatase 640 U/L, alanine aminotransferase 60 U/L). Nothing abnormal was found on abdominal examination but a computed tomographic (CT) scan revealed a well circumscribed mass, 5 cm in longest diameter, in the head of the pancreas, partly cystic and partly solid (Figure 1) .
At laparotomy the tumour was found to have a capsule and to be displacing rather than in®ltrating the adjacent tissues. The common bile duct (CBD) was distended. The tumour was mobilized from the adjacent duodenum and inferior vena cava and enucleated without dif®culty from the head of the pancreas. Because of the deep jaundice and the chronic external pressure on the intrapancreatic portion of the CBD the operation was completed with a choledochoduodenostomy. On histological examination the pancreatic lesion proved to be a papillary cystic tumour which was completely non-in®ltrative ( Figure 2 ). The resection margins were tumour-free. 5 years postoperatively the patient remains in excellent health, without clinical or radiological evidence of local recurrence or distant metastasis.
COMMENT
Only 157 cases of PCENP have been reported since the ®rst description by Frantz in 1959 1 . Before then, and perhaps also since, these tumours may sometimes have been mistaken for adenocarcinoma of the pancreas 2 Ðhence the long survivals in occasional patients with supposed adenocarcinoma. The mean age of appearance is 21.8 years and half the patients are under 19 3 . Only 8 male patients have ever been reported 4 . With most PCENP, the characteristics are those of a benign or low-grade-malignant tumour. In 21 of the 157 cases the behaviour was more aggressive, with in®ltration of surrounding tissues or metastases 5 . The predominance of young women points to a hormonal in¯uence; the histogenesis is unknown, but a neuroendocrine derivation is possible since neuron-speci®c-enolase-positive granules have been identi®ed.
The possibility of PCENP should always be considered when a cystic pancreatic mass is discovered in a young woman. Complete surgical cure of this neoplasm is feasible by resection with disease-free margins. 
